Moreover, Kaplan-Meier analysis indicated that among patients with bladder cancer treated with immunotherapy, low NKILA expression resulted in longer OS compared with high NKILA expression (HR, 0.64; 95% CI, 0.49-0.83; P < .001) (Figure 2B). This evidence concerns the gene NKILA and urinary bladder carcinoma.